Entero Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2025-08-18.
Entero Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on August 18, 2025. Entero Therapeutics, Inc. trades on Nasdaq as GRDX. The filing reports $3.02M sold. Its industry group is Biotechnology. It names Richard Paolone (Executive Officer, Director), Edward Borkowski (Director), Eric Corbett (Director) (SEC Form D, August 18, 2025).
In its own words: “Grid AI Corp. - From homes to hyperscale campuses, we unite intelligence and infrastructure.” (grid-ai.com, checked November 1, 2026)
Is this your company?
Sell to companies like Entero Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-08-18 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Entero Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind Entero Therapeutics, Inc., from the filings we hold.
Biotechnology raises by companies based in Florida, filed within 90 days of this one, largest first.
Get an email when Entero Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Entero Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Entero Therapeutics, Inc. →Get the full cited report on Entero Therapeutics, Inc.
What the filing shows about Entero Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Entero Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Entero Therapeutics, Inc.'s address as 79014TH St N # 21135, St. Petersburg, FL 33702.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for GridAI Technologies Corp. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Entero Therapeutics, Inc. See pricing
Entero Therapeutics, Inc. is a registered filer with the SEC (CIK 1604191) and has filed since 2022-12-01. 8 filings are on record, the latest on 2026-07-15.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Entero Therapeutics, Inc.'s Form D of 2025-08-18 names Richard Paolone, Edward Borkowski, Eric Corbett and 5 more as its officers, directors or promoters.
Its new offerings report $27.72M sold across 8 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 769 filings in Biotechnology, totalled by week.
Some of the proceeds may be used for general corporate purposes including the payment of salaries and other fees to those listed in Item 3.
Richard Paolone is named as Executive Officer and Director on the Form D that Entero Therapeutics, Inc. filed with the SEC on 18 August 2025, one of 8 people that filing names.
Edward Borkowski is named as Director on the Form D that Entero Therapeutics, Inc. filed with the SEC on 18 August 2025, one of 8 people that filing names.
Eric Corbett is named as Director on the Form D that Entero Therapeutics, Inc. filed with the SEC on 18 August 2025, one of 8 people that filing names.
Manpreet Uppal is named as Director on the Form D that Entero Therapeutics, Inc. filed with the SEC on 18 August 2025, one of 8 people that filing names.
Jack Syage is named as Director on the Form D that Entero Therapeutics, Inc. filed with the SEC on 18 August 2025, one of 8 people that filing names.
Anna Skowron is named as Executive Officer on the Form D that Entero Therapeutics, Inc. filed with the SEC on 18 August 2025, one of 8 people that filing names.
Jason Sawyer is named as Director on the Form D that Entero Therapeutics, Inc. filed with the SEC on 18 August 2025, one of 8 people that filing names.
Geordan Pursglove is named as Director on the Form D that Entero Therapeutics, Inc. filed with the SEC on 18 August 2025, one of 8 people that filing names.
8 people named on the filing — 2 holding an executive role and 6 as directors only.
Named as of the 2025-08-18 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Entero Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Entero Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Entero Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Entero Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Entero Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Entero Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Orlando and Tampa
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/entero-therapeutics-inc-form-d-25000001